Angel investor · CEO, Loyal
Every published round Celine Halioua took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Gamgee | Seed | 23 Aug 2026 | $5.6m | Participant | trysignalbase.com, datapile.co | |
| Gamgee | Seed | 18 Aug 2026 | $4m | Participant | kucoin.com, thesaasnews.com, Dealroom, newshub.medianet.com.au, theunderbite.co |
Companies Celine Halioua has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Gamgee | startup building AI-designed personalized mRNA cancer vaccines for dogs | 18 Aug 2026, Seed | 2 | 0 |
Fund closes reported for Celine Halioua, as distinct from the investments it has made.
Companies Celine Halioua has backed that another company then bought. An exit for the holding, not a deal Celine Halioua did.
| Role | Organisation | Sources |
|---|---|---|
| CEO | Loyal | kucoin.com, Dealroom, newshub.medianet.com.au, theunderbite.co |
Stories naming Celine Halioua. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Veterinary biotech Gamgee has raised a four million dollar seed round led by Founders Fund, launching from Y Combinator to develop personalised mRNA cancer vaccines for dogs.
Also newshub.medianet.com.au·Dealroom·thesaasnews.com·kucoin.com